Dr. Colin - Quel est le type de patients qui pourraient le plus bénéficier de ces nouvelles combinaisons

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

Vous ne voyez pas la forêt derrière les arbres ?